Binding of immunogenic peptides to Ia histocompatibility molecules. 1985
Babbitt, B.P.; Allen, P.M.; Matsueda, G.; Haber, E.; Unanue, E.R.; Babbitt, B.P.; Allen, P.M.; Matsueda, G.; Haber, E.; Unanue, E.R.
Journal of Immunology 175(7): 4163-4165
2005
ISSN/ISBN: 0022-1767 PMID: 16177052 Document Number: 594527
Document emailed within 1 workday
Related Documents
Brondz, B.D.; Anafalova, T.V.; Pavlova, L.S.; Pankratova, E.V.; Kozhich, A.G.; Moshnikov, S.A. 1993: Use of a series of synthetic peptides and purified major histocompatibility complex i (H-2K(b)) molecules for inhibiting T-suppressors, specific for the K(b) molecule, and their induction by peptides in vivo Molekuliarnaia Biologiia 27(4): 773-780Takiguchi, M. 1994: Structure of MHC molecules and binding peptides Nihon Rinsho. Japanese Journal of Clinical Medicine 52(11): 2817-2823
Ishiyama, S.; Matsueda, S.; Jones, L.A.; Efferson, C.; Celestino, J.; Schmandt, R.; Ioannides, C.G.; Tsuda, N.; Chang, D.Z. 2007: Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites International Journal of Oncology 30(4): 889-898
Mecheri, S.; Dannecker, G.; Dennig, D.; Hoffmann, M.K. 1990: Immunogenic peptides require an undisturbed phospholipid cell membrane environment and must be amphipathic to immobilize Ia on B cells Journal of Immunology 144(4): 1369-1374
Williams, D.B.; Barber, B.H.; Flavell, R.A.; Allen, H. 1989: Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class i histocompatibility molecules Journal of Immunology 142(8): 2796-2806
Nevala, W.K.; Paul, C.; Wettstein, P.J. 1998: Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation Transplantation 65(4): 559-569
Fukatsu, A.; Matsuo, S.; Yuzawa, Y.; Miyai, H.; Futenma, A.; Kato, K. 1993: Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys Laboratory Investigation; A Journal of Technical Methods and Pathology 69(1): 58-67
Sawada, T.; Kanzaki, T.; Hashimoto, S.; Suzuki, A.; Yamada, R.; Odawara, M.; Yamamoto, K. 2009: Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients Clinical and Experimental Rheumatology 27(6): 989-992
Choppin, J.; Metzger, J.J.; Bouillot, M.; Briand, J.P.; Connan, F.; Van Regenmortel, M.H.; Levy, J.P. 1986: Recognition of HLA class i molecules by antisera directed to synthetic peptides corresponding to different regions of the HLA-B7 heavy chain Journal of Immunology 136(5): 1738-1744
Rudensky, A.Yu.; Preston-Hurlburt, P.; Hong, S-Cheol.; Barlow, A.; Janeway, C.A. 2016: Pillars Article: Sequence Analysis of Peptides Bound to MHC Class II Molecules. Nature. 1991. 353: 622-627 Journal of Immunology 196(3): 941-946
Zhang, W. 2004: Fluorous tagging strategy for solution-phase synthesis of small molecules, peptides and oligosaccharides Current Opinion in Drug Discovery and Development 7(6): 784-797
De Silva, A.D.; Boesteanu, A.; Song, R.; Nagy, N.; Harhaj, E.; Harding, C.V.; Joyce, S. 1999: Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides Journal of Immunology 163(8): 4413-4420
Heberling, H.J.; Bierwolf, B.; Kuhlmann, E.; Klugmann, T.; Dietel, P.; Fischer, S. 1987: Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 47(6): 331-336
Casado, L.F.; Granados, E.; Algara, P.; Navarro, F.; Martinez-Frejo, M.C.; López-Botet, M. 2001: High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class i molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients Haematologica 86(5): 457-463
Newcomb, J.R.; Cresswell, P. 1993: Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers Journal of Immunology 150(2): 499-507
Gotohda, T. 1993: Investigation of agretopic motifs in T cell responses specific for pigeon cytochrome c related peptides and restricted to I-E molecules Hokkaido Journal of Medical Science 68(6): 801-812
Moser, E.; Pickardt, C.R.; Mann, K.; Engelhardt, D.; Kirsch, C.M.; Knesewitsch, P.; Tatsch, K.; Kreisig, T.; Kurz, C.; Saller, B. 1988: Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses Nuklearmedizin. Nuclear Medicine 27(3): 98-104
Liu, B.; Podack, E.R.; Allison, J.P.; Malek, T.R. 1996: Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors Journal of Immunology 156(3): 1117-1125
Saiki, I.; Iida, J.; Murata, J.; Ogawa, R.; Nishi, N.; Sugimura, K.; Tokura, S.; Azuma, I. 1989: Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules Cancer Research 49(14): 3815-3822
Matsuyama, T.; Winchester, R.; Lee, S.; Shookster, L.; Nunez-Roldan, A. 1988: Identification of the DRw10 DR beta 1-chain allele as encoding a polymorphic class Ii major histocompatibility complex epitope otherwise restricted to DR beta 2 molecules of the DRw53 type Journal of Immunology 140(2): 537-543